Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Buttgereit

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Zeitschrift Fur Rheumatologie|June 12, 2002
[Neuroendocrine-immunologic mechanisms in rheumatic diseases--a congress report]R H Straub, H G Schaible, M Wahle, et al.
Zeitschrift Fur Rheumatologie|August 2, 2015
[Adult onset Still's disease with small vessel vasculitis]P Hoff, B F Hoyer, U Schneider, et al.
Expert Opinion on Pharmacotherapy|September 4, 2016
Can adverse effects of glucocorticoid therapy be prevented and treated?M C van der Goes, C Strehl, F Buttgereit, et al.
The Journal of Rheumatology|May 17, 2000
Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseasesS Sanden, R Tripmacher, R Weltrich, et al.
Acta Reumatologica Portuguesa|April 7, 2015
Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritisT Santiago, J W Jacobs, K G Saag, et al.
Annals of the Rheumatic Diseases|January 29, 2010
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's diseaseL Naumann, E Feist, A Natusch, et al.
Bioscience Reports|August 10, 2002
Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptorsJ D Lünemann, F Buttgereit, R Tripmacher, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMCM Wahle, R P Neumann, F Moritz, et al.
Pediatric Research|January 3, 2001
Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseasesJ Andreae, R Tripmacher, R Weltrich, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritisF Buttgereit, K G Saag, M Cutolo, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Zeitschrift Fur Rheumatologie|June 12, 2002
[Neuroendocrine-immunologic mechanisms in rheumatic diseases--a congress report]R H Straub, H G Schaible, M Wahle, et al.
Zeitschrift Fur Rheumatologie|August 2, 2015
[Adult onset Still's disease with small vessel vasculitis]P Hoff, B F Hoyer, U Schneider, et al.
Expert Opinion on Pharmacotherapy|September 4, 2016
Can adverse effects of glucocorticoid therapy be prevented and treated?M C van der Goes, C Strehl, F Buttgereit, et al.
The Journal of Rheumatology|May 17, 2000
Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseasesS Sanden, R Tripmacher, R Weltrich, et al.
Acta Reumatologica Portuguesa|April 7, 2015
Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritisT Santiago, J W Jacobs, K G Saag, et al.
Annals of the Rheumatic Diseases|January 29, 2010
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's diseaseL Naumann, E Feist, A Natusch, et al.
Bioscience Reports|August 10, 2002
Norepinephrine inhibits energy metabolism of human peripheral blood mononuclear cells via adrenergic receptorsJ D Lünemann, F Buttgereit, R Tripmacher, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Beta2-adrenergic receptors mediate the differential effects of catecholamines on cytokine production of PBMCM Wahle, R P Neumann, F Moritz, et al.
Pediatric Research|January 3, 2001
Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseasesJ Andreae, R Tripmacher, R Weltrich, et al.
Scandinavian Journal of Rheumatology|May 21, 2005
The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritisF Buttgereit, K G Saag, M Cutolo, et al.
Pageof 15